Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

If granted, IXCHIQ^® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older